{"id":34495,"date":"2024-11-26T16:38:54","date_gmt":"2024-11-26T16:38:54","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=34495"},"modified":"2025-01-16T21:47:18","modified_gmt":"2025-01-16T21:47:18","slug":"imppp-improving-medicines-use-in-people-with-polypharmacy-in-primary-care","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/tr\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/nihr-funded-projects\/imppp-improving-medicines-use-in-people-with-polypharmacy-in-primary-care\/","title":{"rendered":"IMPPP: Birinci Basamak Sa\u011fl\u0131k Hizmetlerinde \u00c7oklu \u0130la\u00e7 Kullanan Ki\u015filerde \u0130la\u00e7 Kullan\u0131m\u0131n\u0131n \u0130yile\u015ftirilmesi"},"content":{"rendered":"
Mod\u00fcl-1 ba\u015fl\u0131kl\u0131 b\u00f6l\u00fcm<\/span><\/a>
\r\n
\r\n
\n
\n

IMPPP: Birinci Basamak Sa\u011fl\u0131k Hizmetlerinde \u00c7oklu \u0130la\u00e7 Kullanan Ki\u015filerde \u0130la\u00e7 Kullan\u0131m\u0131n\u0131n \u0130yile\u015ftirilmesi<\/h1>\n<\/div>\n<\/header>\n
\n

<\/h2>\n

Finansman<\/h2>\n<\/article>\n

Ulusal Sa\u011fl\u0131k Enstit\u00fcs\u00fc (NIHR) Sa\u011fl\u0131k Hizmeti ve Sunumu Ara\u015ft\u0131rmalar\u0131 (HS&DR) Ref. 16\/118\/14<\/p>\n

Ara\u015ft\u0131rma sorusu nedir?<\/h2>\n

Genel t\u0131p prati\u011fi ortam\u0131nda \u00e7oklu ila\u00e7 kullanan hastalar i\u00e7in ila\u00e7 kullan\u0131m\u0131n\u0131 optimize etmeye y\u00f6nelik bir m\u00fcdahale geli\u015ftirip de\u011ferlendirebilir miyiz?<\/p>\n

Sorun nedir?<\/h2>\n

Doktorlar\u0131n hastal\u0131klar\u0131 tedavi etmek ve insanlar\u0131n sa\u011fl\u0131\u011f\u0131n\u0131 iyile\u015ftirmek i\u00e7in yapt\u0131\u011f\u0131 en \u00f6nemli i\u015flerden biri ila\u00e7 yazmakt\u0131r.<\/p>\n

Birle\u015fik Krall\u0131k n\u00fcfusu giderek ya\u015flan\u0131yor ve insanlar\u0131n genellikle birden fazla sa\u011fl\u0131k sorunu oluyor. Bu da daha fazla insan\u0131n birden fazla ila\u00e7 kullanmas\u0131 anlam\u0131na geliyor ki buna polifarmasi deniyor.<\/p>\n

\u00c7oklu ila\u00e7 kullan\u0131m\u0131, ki\u015finin sa\u011fl\u0131\u011f\u0131n\u0131 korumas\u0131na yard\u0131mc\u0131 olmak i\u00e7in \u00e7o\u011fu zaman gereklidir, ancak yan etkiler veya hangi ila\u00e7lar\u0131n ne zaman al\u0131nmas\u0131 gerekti\u011fi konusunda kafa kar\u0131\u015f\u0131kl\u0131\u011f\u0131 gibi sorunlara da yol a\u00e7abilir.<\/p>\n

\u00c7oklu ila\u00e7 kullanan ki\u015filerde ila\u00e7 kullan\u0131m\u0131n\u0131 iyile\u015ftirmenin yollar\u0131n\u0131 bulmam\u0131z gerekiyor ki bu sorunlar\u0131n bir k\u0131sm\u0131n\u0131 azaltabilelim. Ancak, sa\u011fl\u0131k profesyonellerinin bunu nas\u0131l yapacaklar\u0131na karar vermelerine yard\u0131mc\u0131 olacak sa\u011flam bir bilimsel kan\u0131t bulunmamaktad\u0131r.<\/p>\n

Ara\u015ft\u0131rman\u0131n amac\u0131 nedir?<\/h2>\n

Bu proje, aile hekimli\u011fine ba\u015fvuran ve birden fazla ila\u00e7 kullanan ki\u015filerde ila\u00e7 kullan\u0131m\u0131n\u0131 iyile\u015ftirmeye y\u00f6nelik etkili bir yakla\u015f\u0131m olu\u015fturmay\u0131 ama\u00e7lamaktad\u0131r.<\/p>\n

\u00c7oklu ila\u00e7 kullan\u0131m\u0131n\u0131 y\u00f6netme \u015feklimizi iyile\u015ftirmek i\u00e7in yeni bir yakla\u015f\u0131m (IMPPP olarak adland\u0131r\u0131lan) geli\u015ftirece\u011fiz.<\/p>\n

IMPPP, pratisyen hekim muayenehanelerinin hastalar i\u00e7in ila\u00e7 de\u011ferlendirmelerini nas\u0131l organize etti\u011fini iyile\u015ftirecektir. Pratisyen hekimlere e\u011fitim, \u00f6deme ve muayenehanelerinin ne kadar iyi performans g\u00f6sterdi\u011fine dair bilgi sa\u011flayarak daha iyi bak\u0131m sunulmas\u0131n\u0131 te\u015fvik edecektir.<\/p>\n

Bu sistem, pratisyen hekimlerin ve eczac\u0131lar\u0131n ila\u00e7lar hakk\u0131nda do\u011fru kararlar vermelerine yard\u0131mc\u0131 olmak i\u00e7in yeni bir bilgisayar program\u0131 kullanacak. Hastalar\u0131n ila\u00e7lar\u0131yla ilgili endi\u015feleri ve istekleri ise merkezde yer almaya devam edecek.<\/p>\n

Bu ara\u015ft\u0131rma, \u00e7oklu ila\u00e7 kullanan ki\u015filerden hangilerinin ila\u00e7lar\u0131nda yap\u0131lacak iyile\u015ftirmelerden en \u00e7ok fayda g\u00f6rebilece\u011fi konusunda bize de\u011ferli bilgiler sa\u011flayacak ve \u00e7oklu ila\u00e7 kullanan ki\u015filerde ila\u00e7 kullan\u0131m\u0131n\u0131 iyile\u015ftirmek i\u00e7in hangi yakla\u015f\u0131mlar\u0131n en iyi sonu\u00e7 verdi\u011fini g\u00f6sterecektir.<\/p>\n

Bu nas\u0131l ba\u015far\u0131lacak?<\/h2>\n

Projemiz 3 b\u00f6l\u00fcmden olu\u015fmaktad\u0131r:<\/p>\n

    \n
  1. \u00d6ncelikle, \u0130sko\u00e7ya'da kullan\u0131lan benzer bir yakla\u015f\u0131ma ili\u015fkin deneyimi olan sa\u011fl\u0131k profesyonelleri ve hastalarla g\u00f6r\u00fc\u015fece\u011fiz. \u00c7oklu ila\u00e7 kullanan ki\u015filerden hangilerinin iyile\u015ftirilmi\u015f bak\u0131mdan en \u00e7ok fayda g\u00f6rece\u011fini anlamam\u0131za yard\u0131mc\u0131 olmas\u0131 i\u00e7in \u0130sko\u00e7ya'daki pratisyen hekim bilgisayar sistemleri taraf\u0131ndan toplanan re\u00e7ete verilerini kullanaca\u011f\u0131z. Bu bilgileri, hastalar\u0131n ve di\u011fer uzmanlar\u0131n yard\u0131m\u0131yla yeni IMPPP y\u00f6ntemini tasarlamak i\u00e7in kullanaca\u011f\u0131z.<\/li>\n
  2. \u0130kinci olarak, IMPPP'yi Bristol'deki 3 aile hekimli\u011fi klini\u011finde test edece\u011fiz. IMPPP ile ilgili herhangi bir sorun olup olmad\u0131\u011f\u0131n\u0131 \u00f6\u011frenmek ve onu geli\u015ftirebilmek i\u00e7in bu kliniklerdeki bireylerle g\u00f6r\u00fc\u015fmeler yapaca\u011f\u0131z.<\/li>\n
  3. \u00dc\u00e7\u00fcnc\u00fcs\u00fc, Bristol ve Staffordshire'da bir klinik \u00e7al\u0131\u015fma y\u00fcr\u00fctece\u011fiz. Bu \u00e7al\u0131\u015fma, IMPPP kullan\u0131lan 27 ameliyat\u0131, mevcut normal uygulama kullan\u0131lan 27 ameliyatla kar\u015f\u0131la\u015ft\u0131racakt\u0131r. IMPPP sonu\u00e7lar\u0131n\u0131n ila\u00e7 g\u00fcvenli\u011fini, sa\u011fl\u0131k hizmetlerinin kullan\u0131m\u0131n\u0131, ya\u015fam kalitesini ve hastalar i\u00e7in tedavi y\u00fck\u00fcn\u00fc azalt\u0131p azaltmad\u0131\u011f\u0131n\u0131 kontrol edece\u011fiz. Ayr\u0131ca IMPPP'nin hastalar, doktorlar ve eczac\u0131lar taraf\u0131ndan kabul edilebilir olup olmad\u0131\u011f\u0131n\u0131 ve IMPPP'nin NHS i\u00e7in maliyet etkilerini de inceleyece\u011fiz.<\/li>\n<\/ol>\n

    Ara\u015ft\u0131rmay\u0131 kim y\u00fcr\u00fct\u00fcyor?<\/h2>\n

    Dr. Rupert Payne, Bristol \u00dcniversitesi, Halk Sa\u011fl\u0131\u011f\u0131 Bilimleri, Akademik Birinci Basamak Sa\u011fl\u0131k Merkezi'nde K\u0131demli \u00d6\u011fretim \u00dcyesi ve Dan\u0131\u015fman Doktor.<\/p>\n

    Daha fazla bilgi:<\/h2>\n

    IMPPP Hakk\u0131nda<\/a><\/p>\n

    Daha fazla bilgi almak veya bu projeye kat\u0131lmak i\u00e7in l\u00fctfen e-posta g\u00f6nderin. bnssg.research@nhs.net<\/a>.<\/p>\n

    Burada ifade edilen g\u00f6r\u00fc\u015fler yazar(lar)a aittir ve NIHR veya Sa\u011fl\u0131k ve Sosyal Bak\u0131m Bakanl\u0131\u011f\u0131'n\u0131n g\u00f6r\u00fc\u015flerini yans\u0131tmayabilir.<\/p>\n <\/div>\r\n <\/section><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

    Section titled module-1 IMPPP: Improving Medicines use in People with Polypharmacy in Primary Care Funding National Institute for Health (NIHR) Health Service & Delivery Research (HS&DR) Ref. 16\/118\/14 What is the research question? Can we develop and evaluate an intervention to optimise medication use for patients with polypharmacy in a general practice setting? What is […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":32881,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-34495","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/34495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/comments?post=34495"}],"version-history":[{"count":3,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/34495\/revisions"}],"predecessor-version":[{"id":36158,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/34495\/revisions\/36158"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/32881"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/media?parent=34495"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/tags?post=34495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}